{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:55:27Z","timestamp":1791230127791,"version":"4.1.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>As the prevalence of patients on antithrombotics is increasing, anesthesiologists must have a firm understanding of these medications and considerations for their periprocedural management. This review details up-to-date periprocedural management of direct oral anticoagulants (DOACs).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>DOACs have favorable pharmacokinetics including quick onset of action and short half-lives. Periprocedural management of DOACs relies heavily on drug half-life as well as procedural risk of bleeding. Other than a few exceptions, the American College of Cardiologists generally recommends complete clearance of oral anticoagulants prior to high-risk bleeding procedures and partial clearance prior to low-risk bleeding procedures. Procedures with little to no clinical risk of bleeding can be performed without any drug interruption or during trough levels. Exceptions to periprocedural DOAC management pertain to electrophysiology procedures.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>With the exception of no clinically relevant bleeding risk or certain electrophysiology procedures, DOACs should be discontinued periprocedurally in accordance with bleeding risks and drug's half-life. Bridging is generally not recommended for DOACs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aco.0000000000000873","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T01:25:01Z","timestamp":1588728301000},"page":"423-431","source":"Crossref","is-referenced-by-count":8,"title":["Updates in periprocedural management of direct oral anticoagulants"],"prefix":"10.1097","volume":"33","author":[{"given":"Jing","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana D.","family":"Oprea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230827","doi-asserted-by":"crossref","first-page":"322","DOI":"10.21037\/atm.2017.06.65","article-title":"Direct oral anticoagulants: analysis of worldwide use and popularity using Google Trends","volume":"5","author":"Lippi","year":"2017","journal-title":"Ann Transl Med"},{"key":"R2-20230827","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11239-019-01954-2","article-title":"Direct oral anticoagulants: a review on the current role and scope of reversal agents","volume":"49","author":"Chaudhary","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"R3-20230827","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1177\/1089253219870627","article-title":"Periprocedural anticoagulation management for nonoperating room anesthesia procedures: a clinical guide","volume":"23","author":"Tao","year":"2019","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"R4-20230827","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2215\/CJN.02170218","article-title":"Clinical pharmacology of oral anticoagulants in patients with kidney disease","volume":"14","author":"Jain","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"R5-20230827","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1814468","article-title":"Apixaban to prevent venous thromboembolism in patients with cancer","volume":"380","author":"Carrier","year":"2019","journal-title":"N Engl J Med"},{"key":"R6-20230827","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJMoa1814630","article-title":"Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer","volume":"380","author":"Khorana","year":"2019","journal-title":"N Engl J Med"},{"key":"R7-20230827","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJMoa1601747","article-title":"Extended thromboprophylaxis with betrixaban in acutely ill medical patients","volume":"375","author":"Cohen","year":"2016","journal-title":"N Engl J Med"},{"issue":"(Suppl E)","key":"R8-20230827","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.1093\/eurheartj\/suy016","article-title":"Pharmacological properties of betrixaban","volume":"20","author":"Huisman","year":"2018","journal-title":"Eur Heart J Suppl"},{"key":"R10-20230827","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMra1206531","article-title":"Management of antithrombotic therapy in patients undergoing invasive procedures","volume":"368","author":"Baron","year":"2013","journal-title":"N Engl J Med"},{"key":"R11-20230827","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/jth.14598","article-title":"Scientific and Standardization Committee Communication: guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: recommendations for standardized reporting of procedural\/surgical bleed risk and patient-specific thromboembolic risk","volume":"17","author":"Spyropoulos","year":"2019","journal-title":"J Thromb Haemost"},{"key":"R12-20230827","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jacc.2016.11.024","article-title":"2017 ACC expert consensus decision pathway for periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation: a report of the American College of Cardiology Clinical Expert Consensus Document Task Force","volume":"69","author":"Doherty","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R13-20230827","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of nonvitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"39","author":"Steffel","year":"2018","journal-title":"Eur Heart J"},{"key":"R14-20230827","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gie.2015.09.035","article-title":"The management of antithrombotic agents for patients undergoing GI endoscopy","volume":"83","author":"Acosta","year":"2016","journal-title":"Gastrointest Endosc"},{"key":"R15-20230827","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jvir.2019.04.017","article-title":"Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions-Part II: Recommendations: endorsed by the Canadian Association for Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe","volume":"30","author":"Patel","year":"2019","journal-title":"J Vasc Interv Radiol"},{"key":"R16-20230827","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1111\/trf.14248","article-title":"Central venous catheter placement in coagulopathic patients: risk factors and incidence of bleeding complications","volume":"57","author":"van de Weerdt","year":"2017","journal-title":"Transfusion"},{"issue":"(Suppl 10)","key":"R17-20230827","doi-asserted-by":"crossref","first-page":"S1022","DOI":"10.21037\/jtd.2017.05.45","article-title":"Management of oral antiplatelet agents and anticoagulation therapy before bronchoscopy","volume":"9","author":"Youness","year":"2017","journal-title":"J Thorac Dis"},{"key":"R18-20230827","doi-asserted-by":"crossref","first-page":"170001","DOI":"10.1183\/16000617.0001-2017","article-title":"Management of antithrombotic agents in patients undergoing flexible bronchoscopy","volume":"26","author":"Abuqayyas","year":"2017","journal-title":"Eur Respir Rev"},{"key":"R19-20230827","doi-asserted-by":"crossref","first-page":"e004263","DOI":"10.1161\/JAHA.116.004263","article-title":"Incidence of bleeding-related complications during primary implantation and replacement of cardiac implantable electronic devices","volume":"6","author":"Nichols","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"R20-20230827","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/europace\/euv190","article-title":"Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS)","volume":"17","author":"Sticherling","year":"2015","journal-title":"Europace"},{"key":"R21-20230827","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/14740338.2017.1325867","article-title":"Thromboembolic and bleeding risks in patients undergoing atrial fibrillation ablation: oral anticoagulation perspectives","volume":"16","author":"Brice\u00f1o","year":"2017","journal-title":"Expert Opin Drug Saf"},{"key":"R22-20230827","doi-asserted-by":"crossref","first-page":"e006714","DOI":"10.1161\/CIRCEP.118.006714","article-title":"Complications and anticoagulation strategies for percutaneous epicardial ablation procedures","volume":"11","author":"Nakamura","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R23-20230827","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/CIRCEP.111.963413","article-title":"Outcomes of cardiac perforation complicating catheter ablation of ventricular arrhythmias","volume":"4","author":"Tokuda","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R24-20230827","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/AAP.0000000000000763","article-title":"Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Fourth Edition)","volume":"43","author":"Horlocker","year":"2018","journal-title":"Reg Anesth Pain Med"},{"key":"R25-20230827","first-page":"225","article-title":"Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications (second edition): guidelines from the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain","volume":"43","author":"Narouze","year":"2018","journal-title":"Reg Anesth Pain Med"},{"key":"R26-20230827","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"R27-20230827","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMoa1501035","article-title":"Perioperative bridging anticoagulation in patients with atrial fibrillation","volume":"373","author":"Douketis","year":"2015","journal-title":"N Engl J Med"},{"key":"R28-20230827","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2019.2431","article-title":"Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant","author":"Douketis","year":"2019","journal-title":"JAMA Intern Med"},{"key":"R29-20230827","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1016\/j.hrthm.2017.05.012","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"14","author":"Calkins","year":"2017","journal-title":"Heart Rhythm"},{"key":"R30-20230827","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.jacep.2019.08.010","article-title":"Significant benefit of uninterrupted DOACs versus VKA during catheter ablation of atrial fibrillation","volume":"5","author":"Romero","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"R31-20230827","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1093\/eurheartj\/ehy413","article-title":"Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2)","volume":"39","author":"Birnie","year":"2018","journal-title":"Eur Heart J"},{"key":"R32-20230827","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJMoa1707278","article-title":"Idarucizumab for dabigatran reversal \u2013 full cohort analysis","volume":"377","author":"Pollack","year":"2017","journal-title":"N Engl J Med"},{"key":"R33-20230827","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/phar.1884","article-title":"Laboratory and clinical monitoring of direct acting oral anticoagulants: what clinicians need to know","volume":"37","author":"Conway","year":"2017","journal-title":"Pharmacotherapy"},{"key":"R34-20230827","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMoa1814051","article-title":"Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors","volume":"380","author":"Connolly","year":"2019","journal-title":"N Engl J Med"}],"container-title":["Current Opinion in Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000000873","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T04:11:46Z","timestamp":1693109506000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000000873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/aco.0000000000000873","relation":{},"ISSN":["0952-7907","1473-6500"],"issn-type":[{"value":"0952-7907","type":"print"},{"value":"1473-6500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6]]}}}